What Happened?
, -based Sage Therapeutics Promoted Nicole Victoria as Associate Director, Quality Compliance
Date of management change: September 25, 2023
, -based Sage Therapeutics Promoted Nicole Victoria as Associate Director, Quality Compliance
Sage Therapeutics is a clinical-stage biopharmaceutical company committed to developing novel medicines to transform the lives of patients with life-altering central nervous system (CNS) disorders. Sage`s lead product candidate, ZULRESSO(TM) (brexanolone) injection, has completed Phase 3 clinical development for postpartum depression and a New Drug Application is currently under review with the U.S. Food and Drug Administration. Sage is developing a portfolio of novel product candidates targeting critical CNS receptor systems, including SAGE-217, which is in Phase 3 development in major depressive disorder and postpartum depression.
Nicole Victoria is Associate Director, Quality Compliance at Sage Therapeutics. Previously, Nicole held various senior legal leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Macdonald Marissa, Bass Damien, Fine Veronique, Allen Lindsey, Ling William, Reeves Lee, Eckelman Derek, McTigue Michael, Lawson Kelsey, Bogdan Frederick, Schmid Fernanda
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.